Cytomos Overview
- Founded
-
2011
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$582K
- Investors
-
4
Cytomos General Information
Description
Developer of a dielectric spectroscopy technology designed to assist in label-free cell analysis for biomedical research. The company's patented cell analysis technology ensures that every cell is analyzed providing granular information on individual cells and the whole sample population, facilitates automated and quantitative sample assessment, phenotypic drug discovery, and stem cell therapy, enabling medical researchers to find functional endpoints that generate high-content fingerprints to prepare the right dose thereby making cell-based diagnostics efficient.
Contact Information
Website
www.cytomos.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
- 13 Melville Street
- Edinburgh EH3 7PE
- Scotland, United Kingdom
+44 0131 000 0000
Cytomos Timeline
Cytomos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | 01-Dec-2022 | $582K | 00.000 | Completed | Generating Revenue | |
| 5. Seed Round | 28-Jun-2022 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 4. Angel (individual) | 24-May-2021 | 00.000 | 00.000 | 00.000 | Completed | Startup |
| 3. Later Stage VC | 23-Apr-2018 | 00.000 | 00.000 | 00.000 | Completed | Startup |
| 2. Early Stage VC | 16-Feb-2016 | $773K | $930K | 00.000 | Completed | Startup |
| 1. Angel (individual) | 15-Dec-2014 | $157K | $157K | 00000 | Completed | Startup |
Cytomos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Ordinary | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Ordinary | 126,050 | $0.000012 | $6.26 | $6.26 | 1x | $6.26 | 15.24% |
Cytomos Patents
Cytomos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-6827505-B2 | Biological detection device | Active | 04-Jul-2013 | 00000000000 | |
| US-10933418-B2 | Biological analysis apparatus | Active | 04-Jul-2013 | 00000000000 | |
| JP-2020003499-A | Biological sensing apparatus | Active | 04-Jul-2013 | 00000000000 | 00 |
| JP-6637882-B2 | Biological detection equipment | Active | 04-Jul-2013 | 00000000000 | |
| EP-3017287-A1 | Biological sensing apparatus | Pending | 04-Jul-2013 | G01N15/1031 | 0 |
Cytomos Executive Team (6)
Cytomos Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alan Raymond | Cytomos | Chairman | 000 0000 |
| Gino Miele Ph.D | Cytomos | Board Member | 000 0000 |
| Margaret Temple | Self | Board Member | 000 0000 |
| Nicola Broughton Ph.D | Self | Board Member | 000 0000 |
| Stewart White Ph.D | Self | Board Member | 000 0000 |
Cytomos Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cytomos Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Innovate UK | Government | 000 0000 | 000000 0 | ||
| Old College Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Scottish Enterprise | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Archangel Investors | Angel Group | Minority | 000 0000 | 000000 0 |